Understanding the biological effects of SARS-CoV-2 persistence in children

FHS
June 29, 2023
7:33 am

Researchers analyzed the most recent knowledge about severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

bit.bio defends European patent for ‘novel’ opti-ox technology – Pharmaceutical Technology

The EPO ruling affirms bit.bio’s European patent for opti-ox, its proprietary stem cell engineering technology. Credit: Yavdat/ Shutterstock bit.bio has successfully defended the European patent

October 16, 2024

Applied Cells opens CellQuest Research Grant to accelerate cutting-edge multiple myeloma research

Applied Cells is thrilled to announce the opening of the CellQuestGrant.

October 2, 2023

Rare condition post-orgasmic illness syndrome explored in depth

Comprehensive review synthesizes current knowledge on post-orgasmic illness syndrome (POIS), a rare condition marked by a range of symptoms following ejaculation, highlighting the need for

March 18, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.